{"id":"NCT00470600","sponsor":"Cumberland Pharmaceuticals","briefTitle":"Efficacy and Safety Study of Caldolor (IV Ibuprofen) in Hospitalized Adult Orthopedic Patients","officialTitle":"A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF IBUPROFEN INJECTION (IVIb) FOR TREATMENT OF PAIN IN POST-OPERATIVE ORTHOPEDIC ADULT PATIENTS","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-05","primaryCompletion":"2008-09","completion":"2008-09","firstPosted":"2007-05-08","resultsPosted":"2011-12-08","lastUpdate":"2015-08-21"},"enrollment":185,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain"],"interventions":[{"type":"DRUG","name":"Caldolor","otherNames":["Ibuprofen"]},{"type":"OTHER","name":"Normal Saline","otherNames":["NS"]}],"arms":[{"label":"Normal Saline","type":"PLACEBO_COMPARATOR"},{"label":"Intravenous ibuprofen","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult orthopedic patients every 6 hours for at least 24 hours is to determine the efficacy of Caldolor (IV ibuprofen) compared to placebo for the treatment of post-operative pain by patients self-assessment of pain.","primaryOutcome":{"measure":"AUC-VAS With Movement (Post-operative Period, Hour-6-28)","timeFrame":"Study hour-6 through hour-28","effectByArm":[{"arm":"Placebo","deltaMin":1326.1,"sd":82},{"arm":"800mg IV Ibuprofen (Caldolor)","deltaMin":1005,"sd":81.5}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":9,"countries":["United States","South Africa"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":86},"commonTop":["Nausea","Vomiting","Constipation","Pyrexia","Pruritis"]}}